Background illustration for clinical trials search

Paid Clinical Trials Plainfield

Discover 2,380 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Chicago IL, St Louis MO, Maumee OH, Rochester MN,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase 2, Recruiting

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

for
Small Bowel Adenocarcinoma
Location: Chicago IL, Fort Wayne IN, St Louis MO, Richmond VA,
Sponsor: Tiago Biachi de Castria

Sex: All

Age: 18+

Code: NCT06835387

Phase 2, Recruiting

BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

for
Nausea With Vomiting Chemotherapy-Induced
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18 - 70+

Code: NCT04150614

Recruiting

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

for
NSCLC, Stage I
Location: Chicago IL, Madison WI, Indianapolis IN, Iowa City IA,
Sponsor: Greg Durm, MD

Sex: All

Age: 18+

Code: NCT04317534

Phase 2, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: Chicago IL, Bettendorf IA, Iowa City IA, St Louis MO,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer

for
Breast Cancer Invasive, Early-stage Breast Cancer,
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT04891068

Phase 2, Recruiting

Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD

for
Multiple Myeloma
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT05192122

Phase 1, Recruiting

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

for
Extensive Stage Lung Small Cell Carcinoma,
Location: Chicago IL, Madison WI, Indianapolis IN, Iowa City IA,
Sponsor: Dwight Owen

Sex: All

Age: 18+

Code: NCT04919382

Phase 2, Recruiting

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

for
Breast Cancer, HER2-positive Breast Cancer,
Location: Chicago IL, Madison WI, Rochester NY, Hershey PA
Sponsor: Ruth O'Regan

Sex: All

Age: 18+

Code: NCT04886531

Phase 2, Recruiting

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Chicago IL, St Louis MO, Louisville KY, Detroit MI,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06295731

Phase 2, Phase 3, Recruiting

LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients

for
NSCLC
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT06576635

Recruiting

Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)

for
Hereditary Cancer Syndrome
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 25+

Code: NCT05664867

Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Chicago IL, Milwaukee WI, Iowa City IA, St Louis MO,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

for
CRC (Colorectal Cancer)
Location: Chicago IL, Evanston IL, Springfield IL,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07284849

Phase 3, Recruiting

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Chicago IL, St Louis MO, Columbus OH, Westwood KS,
Sponsor: AVEO Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06064877

Phase 3, Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Chicago IL, Zion IL, Detroit MI, Nashville TN,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase 1, Recruiting

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

for
Acute Leukemia, MDS
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18 - 70+

Code: NCT04187105

Phase 2, Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
Location: Chicago IL, Zion IL, Oak Creek WI, New Berlin WI,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase 3, Recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

for
Patients With Non-Small Cell Lung Cancer
Location: Chicago IL, Nashville TN, Smyrna TN, Franklin TN,
Sponsor: OSE Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06472245

Phase 3, Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: Chicago IL, St Louis MO, Saint Paul MN,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06172478

Phase 2, Recruiting